检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:黄明[1,2] 孟凡义[1] 郎丽[2] 夏丽华[2] 曾子芳[2] 陈嘉斌[2] 李斌[2] 梁顺华[2] 张莹[2]
机构地区:[1]南方医科大学南方医院,广东广州510515 [2]广东省职业病防治院,广州510300
出 处:《中国职业医学》2011年第2期133-135,共3页China Occupational Medicine
基 金:广东省职业病防治院专项基金(B200604)
摘 要:目的观察苯中毒再生障碍性贫血(BPAA)患者血清中造血负调控因子对正常骨髓造血细胞的影响。方法以BPAA患者为研究对象,用其血清培养健康者骨髓细胞,进行骨髓造血干/祖细胞集落形成单位(CFU)计数,流式细胞仪检测CD34+细胞率及其Fas表达率的变化,同时用酶联免疫吸附法(ELISA)检测血清中干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)、白细胞介素-2(IL-2)的水平。结果 BPAA患者血清培养后骨髓粒-巨噬细胞集落形成单位(CFU-GM)和红系集落形成单位(CFU-E)数量均显著降低(均P<0.05),骨髓CD34+细胞比例显著降低,CD34+细胞的Fas表达率随之显著升高(均P<0.05);血清中IFN-γ、TNF-α、IL-2的水平也明显升高(均P<0.05)。结论 BPAA患者血清中造血负调控因子水平升高,使正常骨髓造血干/祖细胞集落形成受抑制,并上调造血干/祖细胞Fas表达。Objective To study the effect of hematopoietic negative regulatory factors in benzene poisoning aplastic anemia(BPAA) serum on normal bone marrow hematopoietic cells.Methods Bone marrow cells from the healthy were incubated with BPAA serum,then colony-forming unit of bone marrow hematpoietic stem/progenitor cell was counted by microscopy,percentage of CD34+ cells and CD34+ Fas+ cells were analyzed by flow cytometry,serum interferon gamma(IFN-γ),tumor necrosis factor α(TNF-α),and interleukin 2(IL-2) levels were detected by enzyme-linked immunosorbent assay(ELISA).Results After incubated with BPAA serum,the numbers of bone marrow colony-forming unit-granulocyte and macrophage(CFU-GM),colony-forming unit-erythrocyte(CFU-E),as well as the percentage of CD34+ cells decreased significantly(P0.05),while the expression of Fas in CD34+ cells increased(P0.05).The concentrations of IFN-γ,TNF-α and IL-2 in BPAA serum were significantly higher than those of the healthy people(P0.05).Conclusion The levels of hematopoietic negative regulatory factors in BPAA serum raise,which inhibits hematpoietic stem/progenitor cells colony-forming and up-regulates the expression of Fas.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.177